Skip to content

Total Assets at other companies

Merck & Co. logo
Merck & Co.MRK
$128.69B+11.8%
Delcath Systems logo
Delcath SystemsDCTH
$124.84M+43.0%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$925.67M-4.2%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$402.98M-30.5%
Immunome logo
ImmunomeIMNM
$619.79M+80.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$997M-13.8%

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s total assets?
Citius Oncology, Inc. (CTOR) reported total assets of $100.7M in Q1 2026.
How has Citius Oncology, Inc.'s total assets changed year-over-year?
Citius Oncology, Inc.'s total assets increased by 10.1% year-over-year, from $91.44M to $100.7M.
What is the long-term trend for Citius Oncology, Inc.'s total assets?
Over 3 years (2022 to 2025), Citius Oncology, Inc.'s total assets has grown at a 632.6% compound annual growth rate (CAGR), from $256.75K to $100.94M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.